{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:32:21Z","timestamp":1793082741954,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574437"],"award-info":[{"award-number":["82574437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370207"],"award-info":[{"award-number":["82370207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874317"],"award-info":[{"award-number":["81874317"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179413","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:45:37Z","timestamp":1791503137000},"page":"179413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acaudiolide attenuates MASH-related liver fibrosis through covalent engagement of SMAD4 and blockade of p-SMAD2\/3 nuclear translocation"],"prefix":"10.1016","volume":"1037","author":[{"given":"Manman","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-4601","authenticated-orcid":false,"given":"Xingxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179413_bib1","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179413_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9","article-title":"Big effects from small changes: possible ways to explore nature's chemical diversity","volume":"3","author":"Bode","year":"2002","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejphar.2026.179413_bib3","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.cgh.2022.05.056","article-title":"Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B: a phase 2 randomized controlled trial","volume":"21","author":"Cai","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179413_bib4","article-title":"The pivotal role of TGF-\u03b2\/Smad pathway in fibrosis pathogenesis and treatment","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.179413_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179413_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.179413_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","article-title":"TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer","volume":"22","author":"Giarratana","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179413_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.729513","article-title":"Structural biology in the clouds: the WeNMR-EOSC ecosystem","volume":"8","author":"Honorato","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejphar.2026.179413_bib9","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2026.179413_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2026.179413_bib11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2026.179413_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ejphar.2026.179413_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112984","article-title":"Obeticholic acid inhibits hepatic fatty acid uptake independent of FXR in mouse","volume":"150","author":"Lin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179413_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115905","article-title":"Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGF-\u03b2 pathway inhibition","volume":"438","author":"Maher","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179413_bib15","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massagu\u00e9","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2026.179413_bib16","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.3390\/ijms26072959","article-title":"Metabolic-dysfunction-associated steatotic liver disease: molecular mechanisms, clinical implications, and emerging therapeutic strategies","volume":"26","author":"Mej\u00eda-Guzm\u00e1n","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179413_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115712","article-title":"Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study","volume":"168","author":"Poo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179413_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110289","article-title":"Transforming growth factor-\u03b2 signaling: from tissue fibrosis to therapeutic opportunities","volume":"369","author":"Ren","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2026.179413_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41573-025-01158-9","article-title":"Fibrosis: cross-organ biology and pathways to development of innovative drugs","volume":"24","author":"Rieder","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.179413_bib20","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1128\/MCB.25.22.9845-9858.2005","article-title":"Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads","volume":"25","author":"Schmierer","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179413_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41575-025-01068-6","article-title":"Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease","volume":"22","author":"Schwabe","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179413_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/cells14040266","article-title":"Mechanosignaling via integrins: pivotal players in liver fibrosis progression and therapy","volume":"14","author":"Sharip","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179413_bib23","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1021\/acs.orglett.1c02089","article-title":"Acautalides A-C, neuroprotective Diels-Alder adducts from solid-state cultivated Acaulium sp. H-JQSF","volume":"23","author":"Tong","year":"2021","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejphar.2026.179413_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179413_bib25","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.2174\/0109298673288458240203064112","article-title":"Natural products in liver fibrosis management: a five-year review","volume":"31","author":"Wang","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179413_bib26","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/acs.orglett.8b00883","article-title":"Acaulins A and B, trimeric macrodiolides from Acaulium sp. H-JQSF","volume":"20","author":"Wang","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejphar.2026.179413_bib27","article-title":"TGF-\u03b2 inhibitors: the future for prevention and treatment of liver fibrosis?","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179413_bib28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/np500110z","article-title":"Caryophyllene sesquiterpenes from the marine-derived fungus Ascotricha sp. ZJ-M-5 by the one strain-many compounds strategy","volume":"77","author":"Wang","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2026.179413_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179413_bib30","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179413_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2024.105831","article-title":"Targeted inhibition of transforming growth factor-\u03b2 type I receptor by AZ12601011 improves paraquat poisoning-induced multiple organ fibrosis","volume":"200","author":"Zhang","year":"2024","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.ejphar.2026.179413_bib32","article-title":"Signaling pathways that activate hepatic stellate cells during liver fibrosis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ejphar.2026.179413_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.14218\/JCTH.2025.00029","article-title":"Exploring the therapeutic potential of TGF-\u03b2 inhibitors for liver fibrosis: targeting multiple signaling pathways","volume":"13","author":"Zhu","year":"2025","journal-title":"J. Clin. Transl. Hepatol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:32:25Z","timestamp":1793079145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0014299926008952"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179413","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acaudiolide attenuates MASH-related liver fibrosis through covalent engagement of SMAD4 and blockade of p-SMAD2\/3 nuclear translocation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179413"}}